Hormonal Health Menstrual & Mood Disorders
PMDD

PMDD.
When It's More Than PMS.

Premenstrual Dysphoric Disorder is a severe, recognised medical condition — not just "bad PMS." Learn the symptoms, neurological causes, diagnosis process and evidence-based treatments.

Affects 3–8% of menstruating women
Recognised in DSM-5 as a diagnosis
Far more severe than PMS
Neurological sensitivity to normal hormonal shifts
SSRIs are the evidence-based first-line
Significantly impairs daily functioning
Overview PMS PMDD Hormonal Mood Changes Cycle-Related Symptoms

Premenstrual Dysphoric Disorder (PMDD) is a severe, cyclical mood disorder driven by an abnormal neurological sensitivity to normal hormonal fluctuations in the luteal phase (days 14–28 of the cycle). It is listed in the DSM-5 and the ICD-11 as a distinct diagnosis — not a variant of PMS or depression.

Recognised diagnosis

Prevalence

3–8%

of menstruating women meet full PMDD criteria

Psychiatric diagnosis

Diagnostic standard

DSM-5

Listed as a depressive disorder — not 'just PMS'

Underdiagnosed

Average delay to diagnosis

5–12 yrs

Most women are misdiagnosed or dismissed first

PMDD vs PMS: The Critical Distinction

PMS

  • Affects up to 75% of women
  • Mild-to-moderate symptoms
  • Manageable with lifestyle changes
  • Mostly physical + mild mood changes

PMDD

  • Affects 3–8% of women
  • Severe, disabling symptoms
  • Requires medical treatment
  • Predominantly severe mood & psychiatric symptoms
Important: PMDD is not caused by abnormal hormone levels. Women with PMDD have normal oestrogen and progesterone — the issue is a neurological hypersensitivity to those normal fluctuations.

PMDD symptoms appear in the luteal phase and resolve within days of menstruation starting. The key distinguishing feature is their severity — these symptoms are disabling, not merely uncomfortable.

Core Mood Symptoms (at least 1 required for diagnosis)DSM-5 core criteria
Marked depressive mood or hopelessness — Not sadness — a profound, dark hopelessness that feels permanent even when intellectually known to be cyclical
Intense anxiety, tension or feeling 'on edge' — Often physical — racing heart, chest tightness, a sense of impending doom
Marked affective lability (mood swings) — Sudden shifts between tearfulness, anger and irritability, often triggered by minor events
Persistent, marked anger or irritability — Disproportionate rage that the woman often recognises is out of character but cannot control
Additional Symptoms (at least 4 total required for diagnosis)Supporting criteria
Decreased interest in usual activities — Withdrawal from hobbies, socialising, relationships — anhedonia
Difficulty concentrating — Brain fog severe enough to impair work performance and decision-making
Fatigue and energy depletion — Profound exhaustion beyond normal tiredness — often worse than any physical PMS symptom
Changes in appetite — Intense food cravings or overeating, or conversely loss of appetite
Sleep disturbance — Hypersomnia or insomnia — difficulty falling asleep, staying asleep or sleeping excessively
Feeling overwhelmed or out of control — A sense of being unable to cope that is disproportionate to actual circumstances
Physical SymptomsAccompanying
Breast tenderness or swelling
Joint or muscle pain
Bloating and weight gain from fluid retention
Headaches or migraines
Suicidality: Thoughts of self-harm or suicide in the luteal phase are a recognised symptom of severe PMDD. If you experience this, seek urgent medical attention — same-day or emergency care. This is a medical emergency, not a character failure.

PMDD cannot be diagnosed from a single consultation — it requires prospective symptom tracking across at least two menstrual cycles. This is both the gold standard and the minimum requirement for an accurate diagnosis.

DSM-5 Diagnostic Criteria (simplified)
At least 5 symptoms in the luteal phase of most cycles in the past year
At least 1 symptom must be a core mood symptom (depression, anxiety, mood lability or anger/irritability)
Symptoms cause clinically significant distress or functional impairment
Symptoms resolve within a few days of menstruation onset
Symptoms are absent in the follicular phase (week after period)
Not explained by another disorder, medication or substance
Tracking Tools

DRSP (Daily Record of Severity of Problems): Validated daily symptom diary rated 1–6. The gold standard — record every day for 2+ cycles before your appointment.

PMDD Screener (Gia App / iCycle): Digital tracking apps with validated PMDD screening built in — useful for appointment preparation.

Cycle chart: At minimum, record when symptoms start, peak and resolve relative to your period each month.

Conditions to Rule Out
Major depressive disorder (present all month)
Generalised anxiety disorder
Bipolar disorder (especially cyclothymia)
Hypothyroidism or thyroid dysfunction
ADHD (often worsens in luteal phase)
Perimenopause hormonal fluctuations
Blood tests: There is no blood test that diagnoses PMDD. However, a hormonal panel, thyroid panel and vitamin D check are recommended to rule out co-existing conditions and guide treatment.

PMDD has highly effective treatments — the evidence base is strong. Treatment is individualised based on symptom severity, reproductive plans, and response to prior interventions.

SSRIs / SNRIs (First-Line)Strongest evidence

Examples: Fluoxetine (Sarafem), Sertraline, Escitalopram, Venlafaxine

SSRIs are the most effective medical treatment for PMDD. Uniquely, they work for PMDD within hours to days rather than the weeks needed for depression — because the mechanism is different (modulating allopregnanolone sensitivity, not just serotonin reuptake). Can be taken continuously or only in the luteal phase (day 14 to day 1 of next period). Luteal-phase dosing works for most women and avoids continuous SSRI use.

Best for: All women with moderate-to-severe PMDD. Also effective for women with co-existing anxiety or depression.

COCP (Drospirenone + EE)Good evidence

Examples: Yaz (20mcg EE + 3mg drospirenone), Yasmin

Suppresses the natural cycle, eliminating the hormonal fluctuations that trigger PMDD. Drospirenone has anti-mineralocorticoid properties that also reduce bloating and fluid retention. FDA-approved specifically for PMDD. The 24/4 regimen (Yaz) is more effective than 21/7 for PMDD due to shorter hormone-free interval.

Best for: Women also wanting contraception, or those who want to avoid SSRIs. Not suitable for migraine with aura, smokers over 35, or those with cardiovascular risk.

Cognitive Behavioural Therapy (CBT)Important adjunct

Examples: Individual CBT with a reproductive mental health focus

CBT specifically adapted for PMDD teaches women to recognise the cyclical nature of symptoms, challenge catastrophic thinking during the luteal phase, and develop coping strategies for the predictable low periods. Strong evidence as an adjunct to medication — and some evidence as a standalone for mild-moderate PMDD.

Best for: All women with PMDD — especially as an adjunct to medication, or for those who prefer non-pharmacological approaches.

GnRH Agonists (with Add-back HRT)Severe/refractory

Examples: Zoladex (goserelin), Lupron — with oestradiol + progesterone add-back

Creates a temporary medical menopause by shutting down ovarian hormone production — eliminates PMDD completely. Add-back HRT maintains bone density and prevents menopausal symptoms. Typically used for 6 months as a diagnostic trial and bridge to surgical treatment.

Best for: Severe, treatment-refractory PMDD not responding to SSRIs or hormonal options. Also used as a diagnostic confirmation — if symptoms resolve completely on GnRH agonist, PMDD is confirmed.

Bilateral Oophorectomy (Last Resort)Permanent cure

Examples: Surgical removal of both ovaries — followed by HRT

The only permanent cure for PMDD. Reserved for severe, refractory cases where all other treatments have failed and symptoms are significantly impairing quality of life. Must be preceded by GnRH agonist trial to confirm diagnosis. Followed by long-term HRT (oestrogen + testosterone for most women).

Best for: Women who have completed their family, have confirmed PMDD diagnosis via GnRH agonist trial, and for whom the condition is severely life-limiting.

Approximate private-pay estimates (2024–2025). Many medical aids cover consultations and core investigations with appropriate referral.

ItemDetailsEst. Cost (ZAR)Med Aid
GP / Gynaecologist ConsultationInitial assessment + symptom diary reviewR450 – R1 800Usually covered
Reproductive Psychiatrist ConsultationSpecialist PMDD / reproductive MH assessmentR1 500 – R3 000Usually covered
Hormonal PanelOestradiol, progesterone, LH, FSH (day 21)R600 – R1 200Usually covered
Full Thyroid PanelTSH, Free T4, Free T3, TPO AbR700 – R1 400Partial
Vitamin D + MagnesiumSerum 25-OH-D + RBC magnesiumR500 – R900Partial
SSRI (Sertraline 50mg)Luteal phase or continuous, monthlyR80 – R250/monthUsually covered
COCP Yaz / YasminDrospirenone-containing pill, monthlyR250 – R500/monthPartial
GnRH Agonist (Zoladex)Monthly injection — 6-month trialR2 000 – R3 500/injectionPartial
CBT (Psychologist, per session)Reproductive mental health focusR1 200 – R2 500/sessionLimited
DEXA Scan (if GnRH used)Baseline bone density before GnRH agonistR900 – R1 800Usually covered
Medical aid tip: Use ICD-10 code N94.3 (Premenstrual tension syndrome) or F32.9 (Depressive episode) for PMDD consultations. Present your completed DRSP chart — documented evidence of cyclical symptoms significantly strengthens pre-authorisation requests.

PMDD affects every area of life — relationships, work, self-image and mental health. Building the right support structures around you is as important as finding the right treatment.

Relationships & Communication

Sharing your DRSP chart or a cycle-phase calendar with a partner helps them understand the predictable nature of your symptoms — and that they are not personal. Couples therapy with a therapist who understands PMDD can be transformative.

Workplace Management

PMDD is a recognised medical condition. In South Africa you are entitled to sick leave for incapacitation. Consider planning lighter workloads, fewer high-stakes meetings and more recovery time in your known luteal phase window.

Cycle Charting as Empowerment

Knowing exactly which days of your cycle are highest risk allows you to plan — postpone difficult conversations, be kinder to yourself, avoid major decisions in the worst days. Predictability reduces the sense of chaos.

Peer Support

The PMDD Global Community (pmdd.community), IAPMD (International Association for Premenstrual Disorders), and Facebook groups for PMDD offer peer connection, treatment information and advocacy resources.

Self-Advocacy with Healthcare Providers

Bring your completed DRSP chart to every appointment. If your symptoms are dismissed, seek a second opinion. PMDD is a real, diagnosable and highly treatable condition — you deserve appropriate care.

Thoughts of self-harm or suicide in the premenstrual phase

→ Seek same-day emergency care — call your doctor, go to an emergency room, or call SADAG (0800 21 22 23). This is a medical emergency.

Symptoms so severe you cannot function at work or care for yourself

→ Urgent specialist referral — PMDD at this severity requires immediate medical management

PMS symptoms worsening significantly over recent cycles

→ Assessment for PMDD, perimenopause or worsening hormonal imbalance — don't wait

Symptoms not resolving after period starts, or present all month

→ This pattern suggests a different diagnosis — thorough psychiatric and hormonal assessment required

SSRIs or COCP tried without adequate response

→ Escalate to reproductive psychiatrist or specialist menopause gynaecologist — more options exist

Articles on PMDD & Reproductive Mental Health

View all

SA Birth Plan Reality Check: Public vs Private

7 min read

Skin changes at 40: normal vs concerning signs

8 min read

Lumpy Breasts Don’t Mean Cancer — What’s Normal

8 min read

Heavy Periods in SA: When to Test for Iron Loss

8 min read

Why Your Period Pain Isn’t Normal — Even SA Doctors Miss It

7 min read

Gestational Diabetes After Birth: Your SA Risk Guide

8 min read

Latest Women's Health Mythbusters

View all

HRT Won’t Give You Breast Cancer — The Real Numbers

9 min read

Stop Rubbing Progesterone Cream On Your Skin

6 min read

5 Collagen Timing Myths SA Women Need to Stop Believing

6 min read

That Progesterone Cream From TikTok Won’t Fix Perimenopause

9 min read

Collagen Creams Can’t Feed Your Dermis — Here’s What Can

6 min read

Your ‘Cortisol Face’ Is Probably Not High Cortisol

8 min read

PMDD in South Africa: What Women Need to Know

PMDD is one of the most significantly underdiagnosed conditions in women’s health globally — and South Africa is no exception. Women with PMDD often spend years, sometimes decades, being told their symptoms are normal, being dismissed as emotional or anxious, or having their severe cyclical psychiatric symptoms treated as a general mood disorder without the underlying hormonal pattern ever being identified. This diagnostic delay causes enormous, preventable suffering.

The neurobiological basis of PMDD has been clarified considerably by research in recent years. The condition is not caused by abnormal hormone levels — women with PMDD have oestrogen and progesterone within the normal range. Rather, it is caused by an abnormal neurological response to the normal hormonal fluctuations of the luteal phase. Research has identified alterations in the GABA-A receptor complex in women with PMDD, specifically in how their neurons respond to allopregnanolone — the neurosteroid metabolite of progesterone. Rather than producing calm, allopregnanolone can trigger anxiety, agitation and dysphoria in women with this neurological vulnerability. This is why PMDD is now understood as a disorder of the brain’s response to hormones, not a disorder of the hormones themselves.

This understanding explains why SSRIs — which enhance serotonergic signalling and appear to modulate allopregnanolone sensitivity — are so effective for PMDD, often at doses lower than those used for depression and working within days rather than weeks. It also explains the importance of symptom-tracking in diagnosis: the temporal relationship between symptoms and the cycle is the diagnostic gold standard, and two cycles of prospective daily tracking using the DRSP is the minimum required for an accurate diagnosis.

For South African women, the HealthLab professional directory connects you with HPCSA-registered gynaecologists, endocrinologists and reproductive psychiatrists who take PMDD seriously and can guide you through evidence-based diagnosis and treatment. If you have been dismissed before, seek a second opinion. PMDD is real, diagnosable, and highly treatable — you deserve care that matches the severity of what you experience.